Kezar Life Sciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.12

+0.09 (+1.49%)

As of Feb 8, 2:19 PM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 4 40%

Hold 6 60%

Sell 0 0%

Price Target

Analyst Price Target +207.4% upside

Low Target $12.87

Average Target $18.81

High Target $22.25

Current Price $6.12

Current
$6.12

Target
$18.81

$12.87 $18.81 avg $22.25

Scenario Analysis

Bear Case

$12.87

110.3%

Low target

Base Case

$18.81

+207.4%

Avg target

Bull Case

$22.25

+263.6%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$18.07

-66.1% from high

52-Week Low

$12.93

+-52.7% from low

Target vs 52W High

$18.81

+4.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%